2024 annual financial data
Vivos Therapeutics 2024 Net margin
Direct answer
Net margin was -74.09%.
Operating income was -11,171,000 USD and net income was -11,136,000 USD.
Operating cash flow was -12,691,000 USD.
Get free Vivos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 15,031,000 USD
- Operating income
- -11,171,000 USD
- Net income
- -11,136,000 USD
- Operating cash flow
- -12,691,000 USD